Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis
There is an established literature on the symptoms and complications of COVID‐19 but the
after‐effects of COVID‐19 are not well understood with few studies reporting persistent …
after‐effects of COVID‐19 are not well understood with few studies reporting persistent …
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
HM Al-Kuraishy, AI Al-Gareeb… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative virus in the
development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations …
development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations …
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study
A Ketkar, V Willey, M Pollack, L Glasser… - … medical research and …, 2023 - Taylor & Francis
Objective To estimate the prevalence of patients with an immunocompromising condition at
risk for COVID-19, estimate COVID-19 prevalence rate (PR) and incidence rate (IR) by …
risk for COVID-19, estimate COVID-19 prevalence rate (PR) and incidence rate (IR) by …
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …
SARS-CoV-2 brain regional detection, histopathology, gene expression, and immunomodulatory changes in decedents with COVID-19
GE Serrano, JE Walker, C Tremblay… - … of Neuropathology & …, 2022 - academic.oup.com
Brains of 42 COVID-19 decedents and 107 non-COVID-19 controls were studied. RT-PCR
screening of 16 regions from 20 COVID-19 autopsies found SARS-CoV-2 E gene viral …
screening of 16 regions from 20 COVID-19 autopsies found SARS-CoV-2 E gene viral …
Amyloid processing in COVID‐19‐associated neurological syndromes
SARS‐CoV‐2 infection can damage the nervous system with multiple neurological
manifestations described. However, there is limited understanding of the mechanisms …
manifestations described. However, there is limited understanding of the mechanisms …
Neurological manifestations of SARS-CoV-2: Complexity, mechanism and associated disorders
K Tyagi, P Rai, A Gautam, H Kaur, S Kapoor… - European Journal of …, 2023 - Springer
Abstract Background Coronaviruses such as Severe Acute Respiratory Syndrome
coronavirus (SARS), Middle Eastern Respiratory Syndrome (MERS) and Severe Acute …
coronavirus (SARS), Middle Eastern Respiratory Syndrome (MERS) and Severe Acute …
Cardiovascular autonomic dysfunction in “Long COVID”: pathophysiology, heart rate variability, and inflammatory markers
KC Marques, JAS Quaresma… - Frontiers in cardiovascular …, 2023 - frontiersin.org
Long COVID is characterized by persistent signs and symptoms that continue or develop for
more than 4 weeks after acute COVID-19 infection. Patients with Long COVID experience a …
more than 4 weeks after acute COVID-19 infection. Patients with Long COVID experience a …
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Abstract Coronavirus disease 2019 (COVID-19) outbreak has become a global public health
emergency and has led to devastating results. Mounting evidence proposes that the disease …
emergency and has led to devastating results. Mounting evidence proposes that the disease …
Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs
M Alvarez, E Trent, BDS Goncalves… - Frontiers in aging …, 2022 - frontiersin.org
COVID-19 is renowned as a multi-organ disease having subacute and long-term effects with
a broad spectrum of clinical manifestations. The evolving scientific and clinical evidence …
a broad spectrum of clinical manifestations. The evolving scientific and clinical evidence …